nodes	percent_of_prediction	percent_of_DWPC	metapath
Clevidipine—CYP1A2—Anagrelide—hematologic cancer	0.0341	0.0464	CbGbCtD
Clevidipine—BCHE—Triamcinolone—hematologic cancer	0.0302	0.041	CbGbCtD
Clevidipine—BCHE—Irinotecan—hematologic cancer	0.0229	0.031	CbGbCtD
Clevidipine—CYP2E1—Thalidomide—hematologic cancer	0.0218	0.0297	CbGbCtD
Clevidipine—CYP2C9—Bexarotene—hematologic cancer	0.0213	0.029	CbGbCtD
Clevidipine—CYP2E1—Dacarbazine—hematologic cancer	0.0188	0.0255	CbGbCtD
Clevidipine—BCHE—Cisplatin—hematologic cancer	0.0186	0.0253	CbGbCtD
Clevidipine—CYP2D6—Lomustine—hematologic cancer	0.0181	0.0246	CbGbCtD
Clevidipine—CYP1A2—Carmustine—hematologic cancer	0.0179	0.0244	CbGbCtD
Clevidipine—CYP2C9—Idarubicin—hematologic cancer	0.0177	0.024	CbGbCtD
Clevidipine—CYP2D6—Idarubicin—hematologic cancer	0.0162	0.0219	CbGbCtD
Clevidipine—CYP2C19—Bortezomib—hematologic cancer	0.0157	0.0213	CbGbCtD
Clevidipine—CYP1A2—Methoxsalen—hematologic cancer	0.0152	0.0207	CbGbCtD
Clevidipine—CYP2E1—Mitoxantrone—hematologic cancer	0.0146	0.0198	CbGbCtD
Clevidipine—CYP1A2—Bortezomib—hematologic cancer	0.0145	0.0197	CbGbCtD
Clevidipine—CYP1A2—Daunorubicin—hematologic cancer	0.0139	0.0188	CbGbCtD
Clevidipine—CYP2D6—Hydroxyurea—hematologic cancer	0.0137	0.0187	CbGbCtD
Clevidipine—CYP2C19—Thalidomide—hematologic cancer	0.0137	0.0186	CbGbCtD
Clevidipine—CYP1A2—Alitretinoin—hematologic cancer	0.0136	0.0185	CbGbCtD
Clevidipine—CYP2C9—Bortezomib—hematologic cancer	0.0131	0.0177	CbGbCtD
Clevidipine—CYP2C19—Teniposide—hematologic cancer	0.0131	0.0177	CbGbCtD
Clevidipine—CYP1A2—Thalidomide—hematologic cancer	0.0126	0.0172	CbGbCtD
Clevidipine—CYP3A4—Bexarotene—hematologic cancer	0.0124	0.0168	CbGbCtD
Clevidipine—CYP2C19—Ifosfamide—hematologic cancer	0.0121	0.0164	CbGbCtD
Clevidipine—CYP2D6—Bortezomib—hematologic cancer	0.012	0.0162	CbGbCtD
Clevidipine—CYP3A4—Lomustine—hematologic cancer	0.0115	0.0156	CbGbCtD
Clevidipine—CYP3A4—Busulfan—hematologic cancer	0.0115	0.0156	CbGbCtD
Clevidipine—CYP2C19—Imatinib—hematologic cancer	0.0115	0.0156	CbGbCtD
Clevidipine—CYP2C9—Thalidomide—hematologic cancer	0.0114	0.0155	CbGbCtD
Clevidipine—CYP1A2—Dacarbazine—hematologic cancer	0.0109	0.0148	CbGbCtD
Clevidipine—CYP2C9—Teniposide—hematologic cancer	0.0109	0.0147	CbGbCtD
Clevidipine—CYP1A2—Imatinib—hematologic cancer	0.0106	0.0144	CbGbCtD
Clevidipine—CYP3A4—Thiotepa—hematologic cancer	0.0103	0.0139	CbGbCtD
Clevidipine—CYP2C9—Ifosfamide—hematologic cancer	0.01	0.0136	CbGbCtD
Clevidipine—CYP2C9—Imatinib—hematologic cancer	0.00958	0.013	CbGbCtD
Clevidipine—CYP2E1—Etoposide—hematologic cancer	0.00919	0.0125	CbGbCtD
Clevidipine—CYP2D6—Imatinib—hematologic cancer	0.00876	0.0119	CbGbCtD
Clevidipine—CYP2C9—Nilotinib—hematologic cancer	0.0087	0.0118	CbGbCtD
Clevidipine—CYP1A2—Dasatinib—hematologic cancer	0.00854	0.0116	CbGbCtD
Clevidipine—CYP3A4—Methoxsalen—hematologic cancer	0.00799	0.0108	CbGbCtD
Clevidipine—CYP2D6—Nilotinib—hematologic cancer	0.00796	0.0108	CbGbCtD
Clevidipine—CYP2D6—Vinorelbine—hematologic cancer	0.00789	0.0107	CbGbCtD
Clevidipine—CYP3A4—Bortezomib—hematologic cancer	0.0076	0.0103	CbGbCtD
Clevidipine—CYP2C19—Prednisone—hematologic cancer	0.00759	0.0103	CbGbCtD
Clevidipine—CYP2E1—Dexamethasone—hematologic cancer	0.00756	0.0103	CbGbCtD
Clevidipine—CYP3A4—Daunorubicin—hematologic cancer	0.00727	0.00987	CbGbCtD
Clevidipine—CYP3A4—Cytarabine—hematologic cancer	0.00641	0.00871	CbGbCtD
Clevidipine—CYP3A4—Teniposide—hematologic cancer	0.00632	0.00857	CbGbCtD
Clevidipine—CYP3A4—Ifosfamide—hematologic cancer	0.00583	0.00791	CbGbCtD
Clevidipine—CYP3A4—Imatinib—hematologic cancer	0.00557	0.00756	CbGbCtD
Clevidipine—CYP1A2—Etoposide—hematologic cancer	0.00532	0.00722	CbGbCtD
Clevidipine—CYP3A4—Ruxolitinib—hematologic cancer	0.00524	0.00712	CbGbCtD
Clevidipine—CYP3A4—Nilotinib—hematologic cancer	0.00506	0.00687	CbGbCtD
Clevidipine—CYP3A4—Vinorelbine—hematologic cancer	0.00502	0.00681	CbGbCtD
Clevidipine—CYP2C9—Cisplatin—hematologic cancer	0.00488	0.00662	CbGbCtD
Clevidipine—CYP2D6—Vinblastine—hematologic cancer	0.00486	0.0066	CbGbCtD
Clevidipine—CYP2C19—Dexamethasone—hematologic cancer	0.00474	0.00643	CbGbCtD
Clevidipine—CYP3A4—Triamcinolone—hematologic cancer	0.00459	0.00623	CbGbCtD
Clevidipine—CYP3A4—Dasatinib—hematologic cancer	0.00447	0.00607	CbGbCtD
Clevidipine—CYP3A4—Mitoxantrone—hematologic cancer	0.00442	0.006	CbGbCtD
Clevidipine—CYP2C9—Dexamethasone—hematologic cancer	0.00394	0.00535	CbGbCtD
Clevidipine—CYP3A4—Betamethasone—hematologic cancer	0.00394	0.00535	CbGbCtD
Clevidipine—CYP3A4—Prednisolone—hematologic cancer	0.00388	0.00527	CbGbCtD
Clevidipine—CYP3A4—Prednisone—hematologic cancer	0.00367	0.00498	CbGbCtD
Clevidipine—CYP2D6—Dexamethasone—hematologic cancer	0.0036	0.00489	CbGbCtD
Clevidipine—CYP3A4—Irinotecan—hematologic cancer	0.00348	0.00472	CbGbCtD
Clevidipine—CYP3A4—Vinblastine—hematologic cancer	0.00309	0.0042	CbGbCtD
Clevidipine—CYP3A4—Vincristine—hematologic cancer	0.00304	0.00413	CbGbCtD
Clevidipine—CYP2D6—Doxorubicin—hematologic cancer	0.00299	0.00406	CbGbCtD
Clevidipine—CYP3A4—Etoposide—hematologic cancer	0.00279	0.00378	CbGbCtD
Clevidipine—CYP3A4—Dexamethasone—hematologic cancer	0.00229	0.00311	CbGbCtD
Clevidipine—CYP3A4—Doxorubicin—hematologic cancer	0.0019	0.00258	CbGbCtD
Clevidipine—Nifedipine—ABCC3—hematologic cancer	0.00047	0.42	CrCbGaD
Clevidipine—Hypersensitivity—Mercaptopurine—hematologic cancer	0.000417	0.00273	CcSEcCtD
Clevidipine—Tachycardia—Nilotinib—hematologic cancer	0.000414	0.00272	CcSEcCtD
Clevidipine—Tachycardia—Imatinib—hematologic cancer	0.000412	0.0027	CcSEcCtD
Clevidipine—Hypersensitivity—Clofarabine—hematologic cancer	0.000411	0.0027	CcSEcCtD
Clevidipine—Hypersensitivity—Daunorubicin—hematologic cancer	0.000411	0.0027	CcSEcCtD
Clevidipine—Acute coronary syndrome—Gemcitabine—hematologic cancer	0.000411	0.00269	CcSEcCtD
Clevidipine—Dyspnoea—Bexarotene—hematologic cancer	0.00041	0.00269	CcSEcCtD
Clevidipine—Dyspnoea—Dasatinib—hematologic cancer	0.00041	0.00269	CcSEcCtD
Clevidipine—Hypersensitivity—Pentostatin—hematologic cancer	0.00041	0.00268	CcSEcCtD
Clevidipine—Dyspnoea—Fludarabine—hematologic cancer	0.000409	0.00268	CcSEcCtD
Clevidipine—Myocardial infarction—Gemcitabine—hematologic cancer	0.000408	0.00268	CcSEcCtD
Clevidipine—CACNA1D—lung—hematologic cancer	0.000406	0.0574	CbGeAlD
Clevidipine—Tachycardia—Cladribine—hematologic cancer	0.000405	0.00265	CcSEcCtD
Clevidipine—CYP2C19—hematopoietic system—hematologic cancer	0.000403	0.0569	CbGeAlD
Clevidipine—Hypotension—Nilotinib—hematologic cancer	0.000397	0.0026	CcSEcCtD
Clevidipine—Hypersensitivity—Idarubicin—hematologic cancer	0.000395	0.00259	CcSEcCtD
Clevidipine—Hypotension—Imatinib—hematologic cancer	0.000395	0.00259	CcSEcCtD
Clevidipine—Hypotension—Cladribine—hematologic cancer	0.000388	0.00254	CcSEcCtD
Clevidipine—Hypersensitivity—Teniposide—hematologic cancer	0.000384	0.00252	CcSEcCtD
Clevidipine—CACNA1D—testis—hematologic cancer	0.000383	0.0541	CbGeAlD
Clevidipine—Acute coronary syndrome—Cisplatin—hematologic cancer	0.000383	0.00251	CcSEcCtD
Clevidipine—Myocardial infarction—Cisplatin—hematologic cancer	0.000381	0.00249	CcSEcCtD
Clevidipine—Vomiting—Nelarabine—hematologic cancer	0.000379	0.00249	CcSEcCtD
Clevidipine—Dyspnoea—Nilotinib—hematologic cancer	0.000379	0.00248	CcSEcCtD
Clevidipine—Dyspnoea—Imatinib—hematologic cancer	0.000376	0.00247	CcSEcCtD
Clevidipine—CACNA1C—lung—hematologic cancer	0.000375	0.053	CbGeAlD
Clevidipine—Headache—Nelarabine—hematologic cancer	0.000374	0.00245	CcSEcCtD
Clevidipine—Dyspnoea—Cladribine—hematologic cancer	0.00037	0.00242	CcSEcCtD
Clevidipine—Tachycardia—Melphalan—hematologic cancer	0.000369	0.00242	CcSEcCtD
Clevidipine—Headache—Methoxsalen—hematologic cancer	0.000365	0.00239	CcSEcCtD
Clevidipine—Vomiting—Mercaptopurine—hematologic cancer	0.00036	0.00236	CcSEcCtD
Clevidipine—Tachycardia—Lenalidomide—hematologic cancer	0.000359	0.00235	CcSEcCtD
Clevidipine—Hypersensitivity—Busulfan—hematologic cancer	0.000356	0.00233	CcSEcCtD
Clevidipine—Vomiting—Daunorubicin—hematologic cancer	0.000355	0.00233	CcSEcCtD
Clevidipine—Vomiting—Clofarabine—hematologic cancer	0.000355	0.00233	CcSEcCtD
Clevidipine—Nausea—Nelarabine—hematologic cancer	0.000354	0.00232	CcSEcCtD
Clevidipine—BCHE—hematopoietic system—hematologic cancer	0.000354	0.05	CbGeAlD
Clevidipine—Hypotension—Melphalan—hematologic cancer	0.000354	0.00232	CcSEcCtD
Clevidipine—CACNA1C—testis—hematologic cancer	0.000354	0.05	CbGeAlD
Clevidipine—Vomiting—Pentostatin—hematologic cancer	0.000353	0.00232	CcSEcCtD
Clevidipine—Vomiting—Anagrelide—hematologic cancer	0.000353	0.00232	CcSEcCtD
Clevidipine—Acute coronary syndrome—Etoposide—hematologic cancer	0.000351	0.0023	CcSEcCtD
Clevidipine—Headache—Clofarabine—hematologic cancer	0.00035	0.00229	CcSEcCtD
Clevidipine—Headache—Daunorubicin—hematologic cancer	0.00035	0.00229	CcSEcCtD
Clevidipine—Myocardial infarction—Etoposide—hematologic cancer	0.000349	0.00229	CcSEcCtD
Clevidipine—Headache—Pentostatin—hematologic cancer	0.000348	0.00228	CcSEcCtD
Clevidipine—Headache—Anagrelide—hematologic cancer	0.000348	0.00228	CcSEcCtD
Clevidipine—Nausea—Methoxsalen—hematologic cancer	0.000346	0.00227	CcSEcCtD
Clevidipine—Acute coronary syndrome—Prednisolone—hematologic cancer	0.000346	0.00227	CcSEcCtD
Clevidipine—Hypersensitivity—Procarbazine—hematologic cancer	0.000345	0.00226	CcSEcCtD
Clevidipine—Hypotension—Lenalidomide—hematologic cancer	0.000344	0.00225	CcSEcCtD
Clevidipine—Myocardial infarction—Prednisolone—hematologic cancer	0.000344	0.00225	CcSEcCtD
Clevidipine—Vomiting—Idarubicin—hematologic cancer	0.000341	0.00223	CcSEcCtD
Clevidipine—Hypersensitivity—Bexarotene—hematologic cancer	0.000339	0.00222	CcSEcCtD
Clevidipine—Hypersensitivity—Dasatinib—hematologic cancer	0.000339	0.00222	CcSEcCtD
Clevidipine—Hypersensitivity—Fludarabine—hematologic cancer	0.000338	0.00221	CcSEcCtD
Clevidipine—Dyspnoea—Melphalan—hematologic cancer	0.000337	0.00221	CcSEcCtD
Clevidipine—Nausea—Mercaptopurine—hematologic cancer	0.000336	0.0022	CcSEcCtD
Clevidipine—Headache—Idarubicin—hematologic cancer	0.000336	0.0022	CcSEcCtD
Clevidipine—Nausea—Clofarabine—hematologic cancer	0.000332	0.00217	CcSEcCtD
Clevidipine—Nausea—Daunorubicin—hematologic cancer	0.000332	0.00217	CcSEcCtD
Clevidipine—Vomiting—Teniposide—hematologic cancer	0.000332	0.00217	CcSEcCtD
Clevidipine—Tachycardia—Bortezomib—hematologic cancer	0.000331	0.00217	CcSEcCtD
Clevidipine—Nausea—Pentostatin—hematologic cancer	0.00033	0.00216	CcSEcCtD
Clevidipine—Nausea—Anagrelide—hematologic cancer	0.00033	0.00216	CcSEcCtD
Clevidipine—CYP1A2—hematopoietic system—hematologic cancer	0.000329	0.0465	CbGeAlD
Clevidipine—Dyspnoea—Lenalidomide—hematologic cancer	0.000328	0.00215	CcSEcCtD
Clevidipine—Headache—Teniposide—hematologic cancer	0.000327	0.00214	CcSEcCtD
Clevidipine—Dyspnoea—Hydroxyurea—hematologic cancer	0.000324	0.00212	CcSEcCtD
Clevidipine—Tachycardia—Vinorelbine—hematologic cancer	0.000323	0.00212	CcSEcCtD
Clevidipine—Hypersensitivity—Chlorambucil—hematologic cancer	0.00032	0.0021	CcSEcCtD
Clevidipine—Nausea—Idarubicin—hematologic cancer	0.000318	0.00209	CcSEcCtD
Clevidipine—Acute coronary syndrome—Triamcinolone—hematologic cancer	0.000318	0.00208	CcSEcCtD
Clevidipine—Hypotension—Bortezomib—hematologic cancer	0.000316	0.00207	CcSEcCtD
Clevidipine—Myocardial infarction—Triamcinolone—hematologic cancer	0.000316	0.00207	CcSEcCtD
Clevidipine—Hypotension—Bleomycin—hematologic cancer	0.000314	0.00206	CcSEcCtD
Clevidipine—Hypersensitivity—Nilotinib—hematologic cancer	0.000313	0.00205	CcSEcCtD
Clevidipine—CYP2C9—hematopoietic system—hematologic cancer	0.000313	0.0442	CbGeAlD
Clevidipine—Hypersensitivity—Imatinib—hematologic cancer	0.000311	0.00204	CcSEcCtD
Clevidipine—Nausea—Teniposide—hematologic cancer	0.00031	0.00203	CcSEcCtD
Clevidipine—Hypotension—Vinorelbine—hematologic cancer	0.000309	0.00203	CcSEcCtD
Clevidipine—Tachycardia—Thiotepa—hematologic cancer	0.000308	0.00202	CcSEcCtD
Clevidipine—Vomiting—Busulfan—hematologic cancer	0.000307	0.00201	CcSEcCtD
Clevidipine—Hypersensitivity—Cladribine—hematologic cancer	0.000306	0.002	CcSEcCtD
Clevidipine—Headache—Busulfan—hematologic cancer	0.000303	0.00198	CcSEcCtD
Clevidipine—Dyspnoea—Bortezomib—hematologic cancer	0.000302	0.00198	CcSEcCtD
Clevidipine—Dyspnoea—Bleomycin—hematologic cancer	0.0003	0.00196	CcSEcCtD
Clevidipine—Renal failure acute—Methotrexate—hematologic cancer	0.000299	0.00196	CcSEcCtD
Clevidipine—Vomiting—Procarbazine—hematologic cancer	0.000298	0.00195	CcSEcCtD
Clevidipine—Tachycardia—Thalidomide—hematologic cancer	0.000298	0.00195	CcSEcCtD
Clevidipine—CYP2E1—hematopoietic system—hematologic cancer	0.000296	0.0418	CbGeAlD
Clevidipine—Dyspnoea—Vinorelbine—hematologic cancer	0.000295	0.00193	CcSEcCtD
Clevidipine—Headache—Procarbazine—hematologic cancer	0.000294	0.00193	CcSEcCtD
Clevidipine—Hypersensitivity—Vinblastine—hematologic cancer	0.000293	0.00192	CcSEcCtD
Clevidipine—Vomiting—Dasatinib—hematologic cancer	0.000292	0.00192	CcSEcCtD
Clevidipine—Vomiting—Bexarotene—hematologic cancer	0.000292	0.00192	CcSEcCtD
Clevidipine—Vomiting—Fludarabine—hematologic cancer	0.000291	0.00191	CcSEcCtD
Clevidipine—Acute coronary syndrome—Dexamethasone—hematologic cancer	0.000289	0.00189	CcSEcCtD
Clevidipine—Acute coronary syndrome—Betamethasone—hematologic cancer	0.000289	0.00189	CcSEcCtD
Clevidipine—Headache—Bexarotene—hematologic cancer	0.000288	0.00189	CcSEcCtD
Clevidipine—Headache—Dasatinib—hematologic cancer	0.000288	0.00189	CcSEcCtD
Clevidipine—Headache—Fludarabine—hematologic cancer	0.000287	0.00188	CcSEcCtD
Clevidipine—Nausea—Busulfan—hematologic cancer	0.000287	0.00188	CcSEcCtD
Clevidipine—Myocardial infarction—Betamethasone—hematologic cancer	0.000287	0.00188	CcSEcCtD
Clevidipine—Myocardial infarction—Dexamethasone—hematologic cancer	0.000287	0.00188	CcSEcCtD
Clevidipine—Tachycardia—Carmustine—hematologic cancer	0.000286	0.00188	CcSEcCtD
Clevidipine—Hypotension—Thalidomide—hematologic cancer	0.000285	0.00187	CcSEcCtD
Clevidipine—Tachycardia—Alitretinoin—hematologic cancer	0.000284	0.00186	CcSEcCtD
Clevidipine—Renal failure acute—Epirubicin—hematologic cancer	0.00028	0.00184	CcSEcCtD
Clevidipine—Hypersensitivity—Melphalan—hematologic cancer	0.000279	0.00183	CcSEcCtD
Clevidipine—Nausea—Procarbazine—hematologic cancer	0.000279	0.00183	CcSEcCtD
Clevidipine—CACNA1D—lymph node—hematologic cancer	0.000278	0.0392	CbGeAlD
Clevidipine—Vomiting—Chlorambucil—hematologic cancer	0.000276	0.00181	CcSEcCtD
Clevidipine—Hypotension—Carmustine—hematologic cancer	0.000274	0.0018	CcSEcCtD
Clevidipine—Nausea—Bexarotene—hematologic cancer	0.000273	0.00179	CcSEcCtD
Clevidipine—Nausea—Dasatinib—hematologic cancer	0.000273	0.00179	CcSEcCtD
Clevidipine—Dyspnoea—Thalidomide—hematologic cancer	0.000272	0.00178	CcSEcCtD
Clevidipine—Nausea—Fludarabine—hematologic cancer	0.000272	0.00178	CcSEcCtD
Clevidipine—Hypotension—Alitretinoin—hematologic cancer	0.000272	0.00178	CcSEcCtD
Clevidipine—Hypersensitivity—Lenalidomide—hematologic cancer	0.000271	0.00178	CcSEcCtD
Clevidipine—Vomiting—Nilotinib—hematologic cancer	0.00027	0.00177	CcSEcCtD
Clevidipine—Vomiting—Imatinib—hematologic cancer	0.000268	0.00176	CcSEcCtD
Clevidipine—Hypotension—Ifosfamide—hematologic cancer	0.000268	0.00176	CcSEcCtD
Clevidipine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000267	0.00175	CcSEcCtD
Clevidipine—CYP2C19—blood—hematologic cancer	0.000267	0.0377	CbGeAlD
Clevidipine—Tachycardia—Mitoxantrone—hematologic cancer	0.000266	0.00174	CcSEcCtD
Clevidipine—Headache—Nilotinib—hematologic cancer	0.000266	0.00174	CcSEcCtD
Clevidipine—Headache—Imatinib—hematologic cancer	0.000265	0.00173	CcSEcCtD
Clevidipine—Vomiting—Cladribine—hematologic cancer	0.000264	0.00173	CcSEcCtD
Clevidipine—Hypotension—Vincristine—hematologic cancer	0.000262	0.00172	CcSEcCtD
Clevidipine—Dyspnoea—Carmustine—hematologic cancer	0.000262	0.00171	CcSEcCtD
Clevidipine—Headache—Cladribine—hematologic cancer	0.00026	0.0017	CcSEcCtD
Clevidipine—Renal failure acute—Doxorubicin—hematologic cancer	0.000259	0.0017	CcSEcCtD
Clevidipine—Dyspnoea—Alitretinoin—hematologic cancer	0.000259	0.0017	CcSEcCtD
Clevidipine—Nausea—Chlorambucil—hematologic cancer	0.000258	0.00169	CcSEcCtD
Clevidipine—CACNA1C—lymph node—hematologic cancer	0.000256	0.0362	CbGeAlD
Clevidipine—Dyspnoea—Ifosfamide—hematologic cancer	0.000256	0.00168	CcSEcCtD
Clevidipine—Hypotension—Mitoxantrone—hematologic cancer	0.000255	0.00167	CcSEcCtD
Clevidipine—Hypotension—Irinotecan—hematologic cancer	0.000255	0.00167	CcSEcCtD
Clevidipine—Vomiting—Vinblastine—hematologic cancer	0.000253	0.00166	CcSEcCtD
Clevidipine—Nausea—Nilotinib—hematologic cancer	0.000252	0.00165	CcSEcCtD
Clevidipine—Acute coronary syndrome—Prednisone—hematologic cancer	0.000251	0.00165	CcSEcCtD
Clevidipine—Nausea—Imatinib—hematologic cancer	0.000251	0.00164	CcSEcCtD
Clevidipine—Myocardial infarction—Prednisone—hematologic cancer	0.00025	0.00164	CcSEcCtD
Clevidipine—Hypersensitivity—Bortezomib—hematologic cancer	0.00025	0.00164	CcSEcCtD
Clevidipine—Headache—Vinblastine—hematologic cancer	0.000249	0.00163	CcSEcCtD
Clevidipine—Hypotension—Gemcitabine—hematologic cancer	0.000248	0.00163	CcSEcCtD
Clevidipine—Hypersensitivity—Bleomycin—hematologic cancer	0.000248	0.00162	CcSEcCtD
Clevidipine—Nausea—Cladribine—hematologic cancer	0.000246	0.00162	CcSEcCtD
Clevidipine—Hypersensitivity—Vinorelbine—hematologic cancer	0.000244	0.0016	CcSEcCtD
Clevidipine—Dyspnoea—Irinotecan—hematologic cancer	0.000243	0.00159	CcSEcCtD
Clevidipine—Dyspnoea—Mitoxantrone—hematologic cancer	0.000243	0.00159	CcSEcCtD
Clevidipine—Tachycardia—Cisplatin—hematologic cancer	0.000242	0.00158	CcSEcCtD
Clevidipine—Vomiting—Melphalan—hematologic cancer	0.000241	0.00158	CcSEcCtD
Clevidipine—CYP3A4—hematopoietic system—hematologic cancer	0.000238	0.0337	CbGeAlD
Clevidipine—Dyspnoea—Gemcitabine—hematologic cancer	0.000237	0.00155	CcSEcCtD
Clevidipine—Nausea—Vinblastine—hematologic cancer	0.000236	0.00155	CcSEcCtD
Clevidipine—CYP2D6—hematopoietic system—hematologic cancer	0.000235	0.0331	CbGeAlD
Clevidipine—BCHE—blood—hematologic cancer	0.000235	0.0331	CbGeAlD
Clevidipine—Vomiting—Lenalidomide—hematologic cancer	0.000234	0.00153	CcSEcCtD
Clevidipine—Hypersensitivity—Thiotepa—hematologic cancer	0.000233	0.00153	CcSEcCtD
Clevidipine—Hypotension—Cisplatin—hematologic cancer	0.000231	0.00152	CcSEcCtD
Clevidipine—Vomiting—Hydroxyurea—hematologic cancer	0.000231	0.00151	CcSEcCtD
Clevidipine—Headache—Lenalidomide—hematologic cancer	0.000231	0.00151	CcSEcCtD
Clevidipine—Headache—Hydroxyurea—hematologic cancer	0.000227	0.00149	CcSEcCtD
Clevidipine—BCHE—bone marrow—hematologic cancer	0.000227	0.0321	CbGeAlD
Clevidipine—Hypersensitivity—Thalidomide—hematologic cancer	0.000225	0.00148	CcSEcCtD
Clevidipine—Nausea—Melphalan—hematologic cancer	0.000225	0.00147	CcSEcCtD
Clevidipine—Tachycardia—Etoposide—hematologic cancer	0.000221	0.00145	CcSEcCtD
Clevidipine—Dyspnoea—Cisplatin—hematologic cancer	0.000221	0.00145	CcSEcCtD
Clevidipine—Nausea—Lenalidomide—hematologic cancer	0.000219	0.00143	CcSEcCtD
Clevidipine—Tachycardia—Prednisolone—hematologic cancer	0.000218	0.00143	CcSEcCtD
Clevidipine—CYP1A2—blood—hematologic cancer	0.000218	0.0308	CbGeAlD
Clevidipine—Hypersensitivity—Carmustine—hematologic cancer	0.000216	0.00142	CcSEcCtD
Clevidipine—Nausea—Hydroxyurea—hematologic cancer	0.000216	0.00141	CcSEcCtD
Clevidipine—Vomiting—Bortezomib—hematologic cancer	0.000215	0.00141	CcSEcCtD
Clevidipine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000214	0.0014	CcSEcCtD
Clevidipine—Vomiting—Bleomycin—hematologic cancer	0.000214	0.0014	CcSEcCtD
Clevidipine—Headache—Bortezomib—hematologic cancer	0.000212	0.00139	CcSEcCtD
Clevidipine—Hypotension—Etoposide—hematologic cancer	0.000212	0.00139	CcSEcCtD
Clevidipine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000212	0.00139	CcSEcCtD
Clevidipine—Vomiting—Vinorelbine—hematologic cancer	0.00021	0.00138	CcSEcCtD
Clevidipine—Headache—Vinorelbine—hematologic cancer	0.000207	0.00136	CcSEcCtD
Clevidipine—CYP2C9—blood—hematologic cancer	0.000207	0.0293	CbGeAlD
Clevidipine—Hypersensitivity—Vincristine—hematologic cancer	0.000206	0.00135	CcSEcCtD
Clevidipine—BCHE—lung—hematologic cancer	0.000206	0.029	CbGeAlD
Clevidipine—Dyspnoea—Etoposide—hematologic cancer	0.000202	0.00133	CcSEcCtD
Clevidipine—Nausea—Bortezomib—hematologic cancer	0.000201	0.00132	CcSEcCtD
Clevidipine—Hypersensitivity—Irinotecan—hematologic cancer	0.000201	0.00132	CcSEcCtD
Clevidipine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000201	0.00132	CcSEcCtD
Clevidipine—Tachycardia—Triamcinolone—hematologic cancer	0.000201	0.00132	CcSEcCtD
Clevidipine—Vomiting—Thiotepa—hematologic cancer	0.000201	0.00132	CcSEcCtD
Clevidipine—Nausea—Bleomycin—hematologic cancer	0.0002	0.00131	CcSEcCtD
Clevidipine—Headache—Thiotepa—hematologic cancer	0.000198	0.0013	CcSEcCtD
Clevidipine—Nausea—Vinorelbine—hematologic cancer	0.000196	0.00129	CcSEcCtD
Clevidipine—CYP2E1—blood—hematologic cancer	0.000196	0.0277	CbGeAlD
Clevidipine—Vomiting—Thalidomide—hematologic cancer	0.000194	0.00127	CcSEcCtD
Clevidipine—BCHE—testis—hematologic cancer	0.000194	0.0274	CbGeAlD
Clevidipine—Headache—Thalidomide—hematologic cancer	0.000191	0.00125	CcSEcCtD
Clevidipine—CYP1A2—lung—hematologic cancer	0.000191	0.027	CbGeAlD
Clevidipine—Nausea—Thiotepa—hematologic cancer	0.000188	0.00123	CcSEcCtD
Clevidipine—Vomiting—Carmustine—hematologic cancer	0.000187	0.00122	CcSEcCtD
Clevidipine—Vomiting—Alitretinoin—hematologic cancer	0.000185	0.00121	CcSEcCtD
Clevidipine—Headache—Carmustine—hematologic cancer	0.000184	0.0012	CcSEcCtD
Clevidipine—Dyspnoea—Triamcinolone—hematologic cancer	0.000183	0.0012	CcSEcCtD
Clevidipine—Vomiting—Ifosfamide—hematologic cancer	0.000183	0.0012	CcSEcCtD
Clevidipine—Hypersensitivity—Cisplatin—hematologic cancer	0.000182	0.0012	CcSEcCtD
Clevidipine—Tachycardia—Dexamethasone—hematologic cancer	0.000182	0.00119	CcSEcCtD
Clevidipine—Tachycardia—Betamethasone—hematologic cancer	0.000182	0.00119	CcSEcCtD
Clevidipine—Headache—Alitretinoin—hematologic cancer	0.000182	0.00119	CcSEcCtD
Clevidipine—Nausea—Thalidomide—hematologic cancer	0.000181	0.00119	CcSEcCtD
Clevidipine—Vomiting—Vincristine—hematologic cancer	0.000178	0.00117	CcSEcCtD
Clevidipine—Headache—Vincristine—hematologic cancer	0.000175	0.00115	CcSEcCtD
Clevidipine—Hypotension—Dexamethasone—hematologic cancer	0.000174	0.00114	CcSEcCtD
Clevidipine—Hypotension—Betamethasone—hematologic cancer	0.000174	0.00114	CcSEcCtD
Clevidipine—Nausea—Carmustine—hematologic cancer	0.000174	0.00114	CcSEcCtD
Clevidipine—Vomiting—Irinotecan—hematologic cancer	0.000173	0.00114	CcSEcCtD
Clevidipine—Vomiting—Mitoxantrone—hematologic cancer	0.000173	0.00114	CcSEcCtD
Clevidipine—Nausea—Alitretinoin—hematologic cancer	0.000173	0.00113	CcSEcCtD
Clevidipine—CYP2E1—lung—hematologic cancer	0.000172	0.0243	CbGeAlD
Clevidipine—Headache—Irinotecan—hematologic cancer	0.000171	0.00112	CcSEcCtD
Clevidipine—Headache—Mitoxantrone—hematologic cancer	0.000171	0.00112	CcSEcCtD
Clevidipine—Nausea—Ifosfamide—hematologic cancer	0.000171	0.00112	CcSEcCtD
Clevidipine—Vomiting—Gemcitabine—hematologic cancer	0.000169	0.00111	CcSEcCtD
Clevidipine—Hypersensitivity—Etoposide—hematologic cancer	0.000167	0.0011	CcSEcCtD
Clevidipine—Headache—Gemcitabine—hematologic cancer	0.000166	0.00109	CcSEcCtD
Clevidipine—Nausea—Vincristine—hematologic cancer	0.000166	0.00109	CcSEcCtD
Clevidipine—Hypersensitivity—Prednisolone—hematologic cancer	0.000165	0.00108	CcSEcCtD
Clevidipine—CYP2E1—testis—hematologic cancer	0.000162	0.0229	CbGeAlD
Clevidipine—Nausea—Irinotecan—hematologic cancer	0.000162	0.00106	CcSEcCtD
Clevidipine—Nausea—Mitoxantrone—hematologic cancer	0.000162	0.00106	CcSEcCtD
Clevidipine—Tachycardia—Prednisone—hematologic cancer	0.000159	0.00104	CcSEcCtD
Clevidipine—CYP3A4—blood—hematologic cancer	0.000158	0.0223	CbGeAlD
Clevidipine—Nausea—Gemcitabine—hematologic cancer	0.000158	0.00103	CcSEcCtD
Clevidipine—Vomiting—Cisplatin—hematologic cancer	0.000157	0.00103	CcSEcCtD
Clevidipine—CYP2D6—blood—hematologic cancer	0.000155	0.0219	CbGeAlD
Clevidipine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000152	0.000994	CcSEcCtD
Clevidipine—Nausea—Cisplatin—hematologic cancer	0.000147	0.000964	CcSEcCtD
Clevidipine—Vomiting—Etoposide—hematologic cancer	0.000144	0.000945	CcSEcCtD
Clevidipine—Headache—Etoposide—hematologic cancer	0.000142	0.000931	CcSEcCtD
Clevidipine—BCHE—lymph node—hematologic cancer	0.000141	0.0199	CbGeAlD
Clevidipine—Headache—Prednisolone—hematologic cancer	0.00014	0.000919	CcSEcCtD
Clevidipine—Nausea—Etoposide—hematologic cancer	0.000135	0.000883	CcSEcCtD
Clevidipine—Nausea—Prednisolone—hematologic cancer	0.000133	0.000871	CcSEcCtD
Clevidipine—Nisoldipine—ABCB1—hematologic cancer	0.000132	0.118	CrCbGaD
Clevidipine—Vomiting—Triamcinolone—hematologic cancer	0.000131	0.000857	CcSEcCtD
Clevidipine—Headache—Triamcinolone—hematologic cancer	0.000129	0.000845	CcSEcCtD
Clevidipine—CYP2D6—testis—hematologic cancer	0.000129	0.0182	CbGeAlD
Clevidipine—Hypotension—Methotrexate—hematologic cancer	0.000127	0.000832	CcSEcCtD
Clevidipine—Tachycardia—Epirubicin—hematologic cancer	0.000124	0.000813	CcSEcCtD
Clevidipine—Nitrendipine—ABCB1—hematologic cancer	0.000124	0.11	CrCbGaD
Clevidipine—Nausea—Triamcinolone—hematologic cancer	0.000122	0.000801	CcSEcCtD
Clevidipine—Dyspnoea—Methotrexate—hematologic cancer	0.000121	0.000794	CcSEcCtD
Clevidipine—Hypersensitivity—Prednisone—hematologic cancer	0.00012	0.000785	CcSEcCtD
Clevidipine—Hypotension—Epirubicin—hematologic cancer	0.000119	0.000779	CcSEcCtD
Clevidipine—Vomiting—Betamethasone—hematologic cancer	0.000119	0.000778	CcSEcCtD
Clevidipine—Vomiting—Dexamethasone—hematologic cancer	0.000119	0.000778	CcSEcCtD
Clevidipine—Headache—Dexamethasone—hematologic cancer	0.000117	0.000767	CcSEcCtD
Clevidipine—Headache—Betamethasone—hematologic cancer	0.000117	0.000767	CcSEcCtD
Clevidipine—Tachycardia—Doxorubicin—hematologic cancer	0.000115	0.000753	CcSEcCtD
Clevidipine—Dyspnoea—Epirubicin—hematologic cancer	0.000113	0.000743	CcSEcCtD
Clevidipine—Nausea—Betamethasone—hematologic cancer	0.000111	0.000727	CcSEcCtD
Clevidipine—Nausea—Dexamethasone—hematologic cancer	0.000111	0.000727	CcSEcCtD
Clevidipine—Hypotension—Doxorubicin—hematologic cancer	0.00011	0.000721	CcSEcCtD
Clevidipine—Amlodipine—ABCB1—hematologic cancer	0.000106	0.095	CrCbGaD
Clevidipine—Dyspnoea—Doxorubicin—hematologic cancer	0.000105	0.000688	CcSEcCtD
Clevidipine—Vomiting—Prednisone—hematologic cancer	0.000103	0.000678	CcSEcCtD
Clevidipine—Headache—Prednisone—hematologic cancer	0.000102	0.000668	CcSEcCtD
Clevidipine—Hypersensitivity—Methotrexate—hematologic cancer	0.0001	0.000656	CcSEcCtD
Clevidipine—Felodipine—ABCB1—hematologic cancer	9.83e-05	0.0878	CrCbGaD
Clevidipine—Nausea—Prednisone—hematologic cancer	9.66e-05	0.000633	CcSEcCtD
Clevidipine—Nifedipine—ABCB1—hematologic cancer	9.51e-05	0.085	CrCbGaD
Clevidipine—Hypersensitivity—Epirubicin—hematologic cancer	9.37e-05	0.000614	CcSEcCtD
Clevidipine—Nicardipine—ABCB1—hematologic cancer	9.36e-05	0.0836	CrCbGaD
Clevidipine—Hypersensitivity—Doxorubicin—hematologic cancer	8.67e-05	0.000568	CcSEcCtD
Clevidipine—Vomiting—Methotrexate—hematologic cancer	8.64e-05	0.000566	CcSEcCtD
Clevidipine—Headache—Methotrexate—hematologic cancer	8.51e-05	0.000558	CcSEcCtD
Clevidipine—Vomiting—Epirubicin—hematologic cancer	8.08e-05	0.00053	CcSEcCtD
Clevidipine—Nausea—Methotrexate—hematologic cancer	8.07e-05	0.000529	CcSEcCtD
Clevidipine—Headache—Epirubicin—hematologic cancer	7.97e-05	0.000522	CcSEcCtD
Clevidipine—Nausea—Epirubicin—hematologic cancer	7.55e-05	0.000495	CcSEcCtD
Clevidipine—Vomiting—Doxorubicin—hematologic cancer	7.48e-05	0.00049	CcSEcCtD
Clevidipine—Headache—Doxorubicin—hematologic cancer	7.37e-05	0.000483	CcSEcCtD
Clevidipine—Nausea—Doxorubicin—hematologic cancer	6.99e-05	0.000458	CcSEcCtD
Clevidipine—CYP2C9—Metabolism—SPHK1—hematologic cancer	8.12e-06	7.91e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ALOX5—hematologic cancer	8.11e-06	7.9e-05	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—PIK3R1—hematologic cancer	8.1e-06	7.89e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—MTHFR—hematologic cancer	7.95e-06	7.74e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	7.87e-06	7.67e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.87e-06	7.66e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NUP98—hematologic cancer	7.86e-06	7.65e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ARNTL—hematologic cancer	7.84e-06	7.64e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—UGT1A1—hematologic cancer	7.8e-06	7.6e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—MTAP—hematologic cancer	7.77e-06	7.57e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	7.66e-06	7.46e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CRABP1—hematologic cancer	7.66e-06	7.46e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ACP5—hematologic cancer	7.63e-06	7.43e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CA9—hematologic cancer	7.63e-06	7.43e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ADCY7—hematologic cancer	7.63e-06	7.43e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NCOA3—hematologic cancer	7.63e-06	7.43e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—NQO1—hematologic cancer	7.6e-06	7.4e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CD44—hematologic cancer	7.6e-06	7.4e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.59e-06	7.39e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.59e-06	7.39e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NUP214—hematologic cancer	7.57e-06	7.38e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NCOR2—hematologic cancer	7.53e-06	7.33e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.5e-06	7.3e-05	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—PIK3CB—hematologic cancer	7.47e-06	7.28e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ALOX5—hematologic cancer	7.46e-06	7.27e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—MTR—hematologic cancer	7.42e-06	7.23e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ABCG2—hematologic cancer	7.42e-06	7.23e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.4e-06	7.2e-05	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—PTEN—hematologic cancer	7.35e-06	7.16e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ENO2—hematologic cancer	7.28e-06	7.09e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NUP98—hematologic cancer	7.23e-06	7.04e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CYCS—hematologic cancer	7.19e-06	7.01e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—IDH1—hematologic cancer	7.17e-06	6.98e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NUP98—hematologic cancer	7.16e-06	6.98e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	7.15e-06	6.96e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ABCC3—hematologic cancer	7.09e-06	6.91e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTO1—hematologic cancer	7.09e-06	6.91e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—TXN—hematologic cancer	7.09e-06	6.91e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTT1—hematologic cancer	7.06e-06	6.87e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NCOA3—hematologic cancer	7.02e-06	6.83e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ADCY7—hematologic cancer	7.02e-06	6.83e-05	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—EP300—hematologic cancer	7.01e-06	6.83e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7e-06	6.82e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NUP214—hematologic cancer	6.97e-06	6.78e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.96e-06	6.77e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.96e-06	6.77e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.95e-06	6.77e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.94e-06	6.76e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—FHL2—hematologic cancer	6.92e-06	6.74e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NUP214—hematologic cancer	6.91e-06	6.73e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—SDC1—hematologic cancer	6.9e-06	6.72e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.83e-06	6.66e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—MTR—hematologic cancer	6.82e-06	6.65e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.82e-06	6.65e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—AGRN—hematologic cancer	6.79e-06	6.61e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—MTR—hematologic cancer	6.77e-06	6.59e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.77e-06	6.59e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ENO2—hematologic cancer	6.69e-06	6.52e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PIK3CG—hematologic cancer	6.68e-06	6.5e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.67e-06	6.49e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ENO2—hematologic cancer	6.63e-06	6.46e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.59e-06	6.42e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.5e-06	6.33e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.49e-06	6.32e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.49e-06	6.32e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.49e-06	6.32e-05	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—PTEN—hematologic cancer	6.46e-06	6.29e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—HMMR—hematologic cancer	6.44e-06	6.27e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—IDH2—hematologic cancer	6.44e-06	6.27e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.44e-06	6.27e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—SDC1—hematologic cancer	6.34e-06	6.18e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—GSTP1—hematologic cancer	6.34e-06	6.17e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.34e-06	6.17e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ALOX5—hematologic cancer	6.32e-06	6.16e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—SDC1—hematologic cancer	6.29e-06	6.13e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.22e-06	6.06e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—CREBBP—hematologic cancer	6.19e-06	6.03e-05	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—EP300—hematologic cancer	6.16e-06	6e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NUP98—hematologic cancer	6.12e-06	5.96e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.05e-06	5.89e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.01e-06	5.85e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—ABCB1—hematologic cancer	6e-06	5.85e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.94e-06	5.79e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.94e-06	5.79e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.93e-06	5.78e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NUP214—hematologic cancer	5.9e-06	5.75e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CA9—hematologic cancer	5.89e-06	5.73e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ACP5—hematologic cancer	5.89e-06	5.73e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PIK3CD—hematologic cancer	5.87e-06	5.72e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CD44—hematologic cancer	5.87e-06	5.71e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NQO1—hematologic cancer	5.87e-06	5.71e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.84e-06	5.69e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—GSTM1—hematologic cancer	5.83e-06	5.67e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—NCOR1—hematologic cancer	5.83e-06	5.67e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.81e-06	5.66e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—ALB—hematologic cancer	5.8e-06	5.64e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—MTR—hematologic cancer	5.78e-06	5.63e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.78e-06	5.63e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.74e-06	5.59e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.67e-06	5.52e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ENO2—hematologic cancer	5.67e-06	5.52e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CYCS—hematologic cancer	5.55e-06	5.4e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PIK3R1—hematologic cancer	5.54e-06	5.4e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—IDH1—hematologic cancer	5.54e-06	5.39e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.51e-06	5.37e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.5e-06	5.36e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.47e-06	5.33e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—TXN—hematologic cancer	5.47e-06	5.33e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.47e-06	5.33e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.41e-06	5.27e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NQO1—hematologic cancer	5.39e-06	5.25e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CD44—hematologic cancer	5.39e-06	5.25e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—SDC1—hematologic cancer	5.37e-06	5.23e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.36e-06	5.22e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NQO1—hematologic cancer	5.35e-06	5.21e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CD44—hematologic cancer	5.35e-06	5.21e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.24e-06	5.1e-05	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—PIK3CA—hematologic cancer	5.19e-06	5.05e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—MTHFR—hematologic cancer	5.15e-06	5.01e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.15e-06	5.01e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.13e-06	5e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PIK3CB—hematologic cancer	5.12e-06	4.98e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYCS—hematologic cancer	5.1e-06	4.97e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.07e-06	4.94e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.07e-06	4.94e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYCS—hematologic cancer	5.06e-06	4.93e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.03e-06	4.9e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.01e-06	4.88e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.01e-06	4.88e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.96e-06	4.83e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.89e-06	4.76e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.88e-06	4.75e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.85e-06	4.72e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.73e-06	4.61e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.72e-06	4.6e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.63e-06	4.51e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.59e-06	4.47e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.59e-06	4.47e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CD44—hematologic cancer	4.57e-06	4.45e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NQO1—hematologic cancer	4.57e-06	4.45e-05	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—PIK3CA—hematologic cancer	4.56e-06	4.44e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NUP214—hematologic cancer	4.55e-06	4.44e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.53e-06	4.41e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.5e-06	4.38e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.5e-06	4.38e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.5e-06	4.38e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.48e-06	4.36e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.46e-06	4.35e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—MTR—hematologic cancer	4.46e-06	4.35e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.46e-06	4.34e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PTEN—hematologic cancer	4.42e-06	4.31e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ENO2—hematologic cancer	4.38e-06	4.26e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	4.33e-06	4.21e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYCS—hematologic cancer	4.32e-06	4.21e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.32e-06	4.2e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.3e-06	4.18e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.26e-06	4.15e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.24e-06	4.13e-05	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—AKT1—hematologic cancer	4.24e-06	4.13e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.22e-06	4.11e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—EP300—hematologic cancer	4.22e-06	4.11e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—SDC1—hematologic cancer	4.15e-06	4.04e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.13e-06	4.03e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.13e-06	4.03e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.1e-06	3.99e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.1e-06	3.99e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CREBBP—hematologic cancer	4.01e-06	3.91e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.97e-06	3.87e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.87e-06	3.77e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.81e-06	3.71e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	3.8e-06	3.7e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—ALB—hematologic cancer	3.75e-06	3.66e-05	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—AKT1—hematologic cancer	3.72e-06	3.62e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.69e-06	3.59e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.65e-06	3.56e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.62e-06	3.53e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.61e-06	3.51e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	3.59e-06	3.5e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.53e-06	3.43e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CD44—hematologic cancer	3.53e-06	3.43e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.5e-06	3.41e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.5e-06	3.41e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.5e-06	3.41e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.34e-06	3.25e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.34e-06	3.25e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.32e-06	3.23e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.32e-06	3.23e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.19e-06	3.11e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PIK3CA—hematologic cancer	3.12e-06	3.04e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.1e-06	3.01e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.09e-06	3.01e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.07e-06	2.99e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.04e-06	2.96e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.94e-06	2.86e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.93e-06	2.86e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ALB—hematologic cancer	2.9e-06	2.82e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PTEN—hematologic cancer	2.86e-06	2.79e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.85e-06	2.77e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.82e-06	2.75e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.78e-06	2.71e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.77e-06	2.7e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—EP300—hematologic cancer	2.73e-06	2.66e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.73e-06	2.66e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.7e-06	2.63e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.7e-06	2.63e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.7e-06	2.63e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.68e-06	2.61e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ALB—hematologic cancer	2.66e-06	2.59e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ALB—hematologic cancer	2.64e-06	2.57e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.6e-06	2.53e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.56e-06	2.49e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.55e-06	2.48e-05	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—AKT1—hematologic cancer	2.55e-06	2.48e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.53e-06	2.46e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.41e-06	2.35e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.39e-06	2.33e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.35e-06	2.29e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.33e-06	2.27e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.29e-06	2.23e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ALB—hematologic cancer	2.26e-06	2.2e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.21e-06	2.15e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.16e-06	2.1e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—EP300—hematologic cancer	2.11e-06	2.05e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.03e-06	1.98e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.02e-06	1.97e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PTEN—hematologic cancer	2.02e-06	1.96e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.01e-06	1.95e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.99e-06	1.94e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—EP300—hematologic cancer	1.94e-06	1.89e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—EP300—hematologic cancer	1.92e-06	1.87e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.86e-06	1.81e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.76e-06	1.72e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ALB—hematologic cancer	1.74e-06	1.7e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.72e-06	1.68e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.67e-06	1.62e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.65e-06	1.61e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—EP300—hematologic cancer	1.64e-06	1.6e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.56e-06	1.52e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.43e-06	1.4e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.42e-06	1.38e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.33e-06	1.29e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.27e-06	1.24e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—EP300—hematologic cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.21e-06	1.18e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.17e-06	1.14e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.16e-06	1.13e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—AKT1—hematologic cancer	9.93e-07	9.67e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.38e-07	9.13e-06	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—AKT1—hematologic cancer	7.66e-07	7.46e-06	CbGpPWpGaD
